Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β

British Journal of Pharmacology

Volumn 118, Issue 6, 1996, Pages 1359-1366

  Papapetropoulos, Andreas ^a   Abou Mohamed, Gamal ^a   Marczin, Nandor ^a   Murad, Ferid ^b   Caldwell, R William ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Molecular Geriatrics Corporation   (United States)

Author keywords

Cyclic GMP; Endotoxin; Guanylate cyclase; Interleukin 1; Polymerase chain reaction; Smooth muscle; Sodium nitroprusside

Indexed keywords

ARGININE; ATRIOPEPTIN II; CYCLIC GMP; ENDOTOXIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; HOMEOSTASIS; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; STEADY STATE; VASODILATATION;

EID: 0029991814     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15545.x     Document Type: Article

References (45)

1. g-methylarginine, an inhibitor of endothelium derived nitric oxide synthesis, is a pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun., 160, 881-886.
2. BRADFORD, M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-253.
3. BRANDWEIN, H.J., LEWICKI, J.A. & MURAD, F. (1981). Reversible inactivation of guanylate cyclase by mixed disulfide formation. J. Biol. Chem., 256, 2958-2962.
4. BREDT, D.S., HWANG, P.M., GLATT, C.E., LOWENSTEIN, C., REED, R.R. & SNYDER, S.H. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351, 714-718.
5. BUECHLER, W.A., NAKANE, M. & MURAD, F. (1991). Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun., 174, 351-357.
6. BUSSE, R. & MULSCH, A. (1991). Induction of nitric oxide synthase by cytokines in vascular smooth and muscle cells. FEBS Lett., 275, 87-90.
7. DE KIMPE, S.J., VAN HEUVEN-NOLSEN, D., VAN AMSTERDAM, J.G.C., RADOMSKI, M.W. & NIJKAMP, F.P. (1994). Induction of nitric oxide release by interferon-γ inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J. Pharmacol. Exp. Ther., 268, 910-915.
8. DINARELLO, C. (1991). Interleukin-1 and Interleukin-1 antagonism. Blood, 77, 1627-1652.
9. EVANS, T., CARPENTER, A. & COHEN, J. (1994). Inducible nitricoxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur. J. Biochem., 219, 563-569.
10. FILIPPOV, G. & BLOCH, K.D. (1993). Soluble guanylate cyclase gene expression is decreased in cultured rat aortic smooth muscle cells exposed to cytokines. Circulation, 88, I-141 Abstract.
11. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
12. GEISEL, J., COOK, J.A., COFFEE, K.A., WISE, W.C. & HALUSHKA, P.V. (1991). Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation. Biochim. Biophys. Acta, 1085, 15-20.
13. GEISTERFER, A.A.T., PEACH, M.J. & OWENS, G.K. (1988). Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res., 62, 749-756.
14. GIERSE, J.K., HAUSER, S.D., CREELY, D.P., KODOLDT, C., RANGWALA, S.H. & ISAKSON, P.C. (1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclooxyganase. Biochem J., 305, 479-484.
15. GRISCAVAGE, J.M., ROGERS, N.E., SHERMAN, M.P. & IGNARRO, L.J. (1993). Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by NO. J. Immunol., 151, 6329-6337.
16. HARRISON, D.G., MINOR, R.L., GUERRA, R., QUILLEN, J.E. & SELLKE, F.W. (1991). Endothelial dysfunction in atherosclerosis. In: Cardiovascular Significance of Endothelium-Derived Vasoactive Factors ed. Rubanyi, G.M., New York: Futura. p. 263.
17. HENRY, P.J., DRUMMER, O.H. & HOROWITZ, J.D. (1989). S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br. J. Pharmacol., 98, 757-766.
18. HOLZMANN, S. (1982). Endothelium-induced relaxation by acetylcholine is associated with larger rises in cyclic GMP in coronary arterial strips. J. Cyclic Nucleotide Res., 8, 409-419.
19. JANSSENS, S.P., SHIMOUCHI, A., QUERTERMOUS, T., BLOCH, D.B. & BLOCH, K.D. (1992). Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem., 267, 14519-14522.
20. KATSUKI, S., ARNOLD, W., MITTAL, C. & MURAD, F., (1977). Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res., 3, 23-35.
21. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 87, 3629-3632.
22. KISHIMOTO, I., NAKAO, K., SUGA, S.I., HOSODA, K., YOSHIMASA, T., ITOH, H. & IMURA, H., (1993). Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am. J. Physiol., 256, H1373-1379.
23. KOJDA, G., BECK, J.K., MEYER, W. & NOACK, E., (1994). Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium. Br. J. Pharmacol, 112, 533-540.
24. KOUREMBANAS, S., MCQUILLAN, L.P., LEUNG, G.K. & FALLER, D.V. (1993). Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest., 92, 99-104.
25. KUBES, P., SUZUKI, M. & GRANGER, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
26. LEWICKI, J.A., CHANG, B. & MURAD, F. (1983). Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay. J. Biol. Chem., 258, 3509-3515.
27. LÜSCHER, T.F., VANHOUTTE, P.M., BOULANGER, C., DOHI, Y. & BÜHLER, F.R. (1991). Endothelial dysfunction in hypertension. In Cardiovascular Signifiance of Endothelium-Derived Vasoactive Factors ed. Rubanyi, G.M., Mount Kisco, N.Y., Futura Publishing Co, 199 221.
28. MAGRINAT, G., MASON, S.N., SHAMI, P.J. & WEINBERG, J.B. (1992). Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood, 80, 1880-1884.
29. MARCZIN, N., CHEN, X-L. & CATRAVAS, J.D. (1993a). Response of endothelial cells to oxidant stress. In Vascular Endothelium: Physiological Basis of Clinical Problems II ed. Catravas, J.D., Callow, A.D. & Ryan, U.S., New York, Plenum Press, 3 16.
30. MARCZIN, N., PAPAPETROPOULOS, A., JILLING, T. & CATRAVAS, J.D. (1993b). Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents. Br. J. Pharmacol., 109, 603 605.
31. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
32. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051 3064.
33. NAVA, E., PALMER, R.M.J. & MONCADA, S. (1991). Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet, 338, 1555-1557.
34. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
35. PAPAPETROPOULOS, A., GO. C., MURAD, F. & CATRAVAS, J.D. (1996). Mechanisms of tolerance to sodium nitroprusside in cultured rat aortic smooth muscle cells. Br. J. Pharmacol., 117, 147-155.
36. PAPAPETROPOULOS, A., MARCZIN, N., MORA, G., MILICI, A., MURAD, F. & CATRAVAS, J.D. (1995). Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension, 26, 696-704.
37. POTTER, L.R. & GARBERS, D.L. (1994). Protein-kinase C dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J. Biol. Chem., 269, 14636-14642.
38. SCHRECK, R.P., RIEBER & BAEUERLE, P.A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-B transcription factor and HIV-1. EMBO J., 10, 2247-2258.
39. SEDLAK, J. & LINDSAY, R.H. (1968). Estimation of total, protein bound and nonprotein sulfhydryls groups in tissue with Ellman's reagent. Anal. Biochem., 25, 192-205.
40. SHIMOUCHI, A., JANSSENS, S.P., BLOCH, D.B., ZAPOL, W.M. & BLOCH, D.B. (1993). cAMP regulates soluble guanylate cyclase β1-subunit gene expression in RLF-6 rat fetal lung fibroblasts. Am. J. Physiol., 265, L456-L461.
41. TSUCHIDA, S., HIRAOKA, M., SUDO, M., KIGOSHI, S. & MURAMATSU, I. (1994). Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am. J. Physiol., 267, H2305-H2310.
42. UJIIE, K., DREWETT, J.G., YUEN, P.S.T. & STAR, R.A. (1993). Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. J. Clin. Invest., 91, 730-734.
43. WALDMAN, S.A. & MURAD, F. (1987). Cyclic GMP synthesis and function. Pharmacol. Rev., 39, 163-196.
44. WEI, J., MILICI, A. & BUCCAFUSCO, J.J. (1995). Alterations in the expression of the genes encoding specific muscarinic receptor subtypes in the hypothalamus of spontaneously hypertensive rats. Circ. Res., 76, 142 147.
45. XIE, Q., CHO, H.J., CALAYCAY, J., MUMFORD, R.A., SWIDEREK, K.M., LEE, T.D., DING, A., TROSO, T. & NATHAN, C. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225 228.